Effects of LX4211, a Dual SGLT1/SGLT2 Inhibitor, Plus Sitagliptin on Postprandial Active GLP-1 and Glycemic Control in Type 2 Diabetes
Authors:
- Brian ZambrowiczBZBrian Zambrowicz
- Zhi-Ming DingZDZhi-Ming Ding
- Ike OgbaaIOIke Ogbaa
- Kenny FrazierKFKenny Frazier
- Phillip BanksPBPhillip Banks
- Anne TurnageATAnne Turnage
- Joel FreimanJFJoel Freiman
- Melinda SmithMSMelinda Smith
- Dennis RuffDRDennis Ruff
- Arthur SandsASArthur Sands
- David PowellDPDavid Powell
- 1 March 2013
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 35 (3) , 273-285.e7
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Epidemiology and Economic Impact of Obesity and Type 2 DiabetesSurgical Clinics of North America, 2011
- Diabesity: an overview of a rising epidemicNephrology Dialysis Transplantation, 2010
- Projecting the Future Diabetes Population Size and Related Costs for the U.S.Diabetes Care, 2009
- Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trialsThe Lancet, 2009
- 10-Year Follow-up of Intensive Glucose Control in Type 2 DiabetesNew England Journal of Medicine, 2008
- Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 DiabetesNew England Journal of Medicine, 2005
- Prevalence of Obesity, Diabetes, and Obesity-Related Health Risk Factors, 2001JAMA, 2003
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993